ENDRA Life Sciences (NDRA) executive Thornton sold 33,750 shares for $82.4K at an average $2.44 under a 10b5-1 plan
Insider transactions reported
Michael Milos Thornton (executive at ENDRA Life Sciences Inc., NDRA) reported that they sold 33,750 shares for $82.4K at an average $2.44 between Mar 29, 2021 and Apr 7, 2021. After these transactions the filing shows 259,960 shares held directly.
- Reporting person
- Thornton Michael Milos
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 29, 2021 | Open-market sale (S) | Common Stock1, 2 | -18,750 | $2.37 | $44.4K | 274,960 direct |
| Apr 7, 2021 | Open-market sale (S) | Common Stock1, 3 | -15,000 | $2.53 | $38K | 259,960 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Apr 5, 2021 | Grant or award (A) | Stock OptionsOn 50,000 Common Stock4 | +50,000 | - | - | 50,000 direct |
Holdings before and after
- Common Stock: 293,710 to 259,960 direct
- Stock Options: 0 to 50,000 direct
Footnotes from the filing
- 1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- 2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.35 to $2.39, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- 4. This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Thornton report in this NDRA Form 4?
Michael Milos Thornton (executive at ENDRA Life Sciences Inc., NDRA) reported that they sold 33,750 shares for $82.4K at an average $2.44 between Mar 29, 2021 and Apr 7, 2021. After these transactions the filing shows 259,960 shares held directly.
How many NDRA shares does Thornton hold after this filing?
The filing shows 259,960 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this NDRA insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for NDRA
Earlier insider filings at NDRA
- Apr 7, 2021SEC Form 4 filed by Roger Francois Michelon
- Mar 25, 2021SEC Form 4 filed by Lou Basenese
- Mar 25, 2021SEC Form 4 filed by Anthony Digiandomenico
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2017
Follow NDRA and get a push notification the moment its next story breaks.